…molecules that catalysed their own synthesis. Viroids have properties that make them candidates for survivors of the RNA world: small genome size (to avoid error catastrophe caused by error-prone replication),…
…This property is useful for controlling outbreaks in communities and institutions. Daiichi Sankyo Co. started a Phase III trial for adults and a pediatric Phase II/III trial with CS-8958 in…
…viral resistance are continuing problems. Is there an alternative for AIDS patients? The results of a phase 2 gene therapy trial suggest that gene therapy with an anti-HIV ribozyme could…
An Australian group has reported results of a clinical trial to determine the safety and immunogenicity of a 2009 pandemic H1N1 influenza virus vaccine. Twenty-one days after the first of…
Hosts: Vincent Racaniello and Dickson Despommier Vincent and Dickson discuss the promising results of a phase III trial of a malaria vaccine in African children. [powerpress url=”http://traffic.libsyn.com/twip/TWiP031.mp3″] Click the arrow…
…and survived better than the unaltered lymphocytes, probably because they were at least partially resistant to HIV infection. This important clinical trial is only the beginning of a new approach…
